Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Acute Kidney Injury: Friend, Foe, or Acquaintance?

被引：5
|
作者：
Coca, Steven G. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, One Gustave Levy Pl,POB 1243, New York, NY 10029 USA
来源：
AMERICAN JOURNAL OF NEPHROLOGY | 2020年 / 51卷 / 04期
关键词：
PROGRESSION; RISK; AKI;
D O I：
10.1159/000505896
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [31] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
  • [32] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [33] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [34] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [35] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [36] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [37] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
    Tscharre, Maximilian
    Wadowski, Patricia P.
    Weikert, Constantin
    Pultar, Joseph
    Eichelberger, Beate
    Panzer, Simon
    Gremmel, Thomas
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (06) : 1183 - 1190
  • [38] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in acute coronary syndrome: implications for platelet reactivity?
    Tscharre, M.
    Wadowski, P.
    Weikert, C.
    Pultar, J.
    Eichelberger, B.
    Panzer, S.
    Gremmel, T.
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S43 - S45
  • [39] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
    Maximilian Tscharre
    Patricia P. Wadowski
    Constantin Weikert
    Joseph Pultar
    Beate Eichelberger
    Simon Panzer
    Thomas Gremmel
    Cardiovascular Drugs and Therapy, 2021, 35 : 1183 - 1190
  • [40] Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Acute Kidney Disease after an Episode of AKI: A Multicenter Prospective Cohort Study
    Hines, Abigail
    Li, Xilong
    Ortiz-Soriano, Victor
    Saleh, Sherif
    Litteral, Jamie
    Ruiz-Conejo, Marice
    Wald, Ron
    Silver, Samuel A.
    Neyra, Javier A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (04) : 266 - 275
12345